Effects of Prehospital Traige and Diagnosis of ST Segment Elevation Myocardial Infarction on Mortality Rate

Reza Alizadeh1, Ziba Aghsaeifard2, Mostafa Sadeghi3

  • 1Department of Anesthesiology and Intensive Care, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.

Insights

Prehospital diagnosis of ST segment elevation myocardial infarction (STEMI) using emergency medical services (EMS) and telecardiology significantly reduces door-to-balloon time. This approach may positively impact STEMI patient mortality rates.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Medical Technology

Background:

  • ST segment elevation myocardial infarction (STEMI) outcomes are time-dependent.
  • Timely diagnosis and management are critical for reducing adverse events and mortality.
  • Prehospital emergency medical service (EMS) interventions can influence STEMI patient care pathways.

Purpose of the Study:

  • To evaluate the impact of prehospital STEMI diagnosis via EMS on patient mortality.
  • To compare outcomes between STEMI patients managed with and without EMS referral.
  • To assess the role of telecardiology in prehospital STEMI management.

Main Methods:

  • Retrospective analysis of 424 STEMI patients undergoing primary angioplasty.
  • Categorization into three groups: no EMS, no PPCI, and EMS with telecardiology.
  • Evaluation of door-to-balloon time, mortality (in-hospital, 6-month, 1-year, 3-year), and left ventricular ejection fraction.

Main Results:

  • Prehospital diagnosis with telecardiology (Group C) showed the shortest door-to-balloon time (57.78 min) compared to no EMS (Group A: 141.70 min).
  • Group C exhibited lower mortality rates across all time points, though not statistically significant.
  • Left ventricular ejection fraction was significantly higher in the prehospital diagnosis group (Group C).

Conclusions:

  • Prehospital diagnosis of STEMI utilizing EMS and telecardiology significantly reduces door-to-balloon time.
  • This approach shows potential for improving short-term and long-term mortality in STEMI patients.
  • Telecardiology integration in EMS enhances STEMI patient management efficiency.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
459
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
119
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
243
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
644
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
144